Ameer Harp
Internal Medicine · Dearborn, MINPI 1568954253
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 116 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AstraZeneca at 34.0% of the total. 2025 is the largest year on record at $1,924, more than ten times the $154 reported in 2022.
Across 116 payments — averaging $24.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$968
- Boehringer Ingelheim$327
- Livanova USA, Inc.$281
- Exact Sciences$190
- Lilly USA, LLC$170
- GSK$139
- plus $770 from 15 others
What the payments were for
- Food & beverage$2,846100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 39 | $968 |
| Boehringer Ingelheim | 10 | $327 |
| Livanova USA, Inc. | 3 | $281 |
| Exact Sciences | 8 | $190 |
| Lilly USA, LLC | 9 | $170 |
| GSK | 7 | $139 |
| Sumitomo Pharma America, Inc. | 6 | $135 |
| Ardelyx, Inc. | 6 | $101 |
| Merck | 5 | $97 |
| Pfizer | 4 | $81 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $71 |
| AbbVie | 3 | $62 |
| Shield Therapeutics Inc | 2 | $43 |
| Phathom Pharmaceuticals, Inc. | 2 | $42 |
| Amgen | 2 | $30 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $20 |
| Novo Nordisk | 1 | $18 |
| Actelion Pharmaceuticals US, Inc. | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $16 |
| Verona Pharma, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR$239
- AIRSUPRA$134
- JARDIANCE$125
- BREZTRI$125
How this compares
$2,846 in reported general payments places this provider in the 85th percentile of 4,567 internal medicine providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ventolin HfaAlbuterol Sulfate | 14 | $861 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 20 | $710 |
| Lisinopril | 17 | $134 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Dearborn
- Wassim YounesDearborn$136K
- Ziad BerriDearborn$31K
- Mohamad KhansaDearborn$30K
- Abdulhassan SaadDearborn$28K
- Terry SmithAnn Arbor$2.3M
- Michael ValituttoKalamazoo$1.8M
- Ulka VaishampayanAnn Arbor$996K
- Tina AbrahamPontiac$834K
- Steven KatzmanLivonia$715K
- Adam FormanSouthfield$453K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.